E-LIB Suche - Ergebnisse für: Aguilar-Company, J

1

Immune checkpoint inhibitor therapy and outcomes from SARS-..:

Cortellini, A ; Dettorre, GM ; Dafni, U...
ARTN e005732. , 2023

Link: https://repository.icr.a..

2

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in..:

Cortellini, A ; Tabernero, J ; Mukherjee, U...
The Lancet Oncology. , 2023

Link: http://hdl.handle.net/10..

3

Prior immune checkpoint inhibitor (ICI) therapy is associat..:

Mostaghim, A ; Minkove, S ; Aguilar-Company, J...
International Journal of Infectious Diseases. , 2023

Link: http://hdl.handle.net/10..

4

Persistence of long-term COVID-19 sequelae in patients with..:

Cortellini A ; Salazar R ; Gennari A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000808141900002. , 2022

Link: https://hdl.handle.net/1..

5

Immune checkpoint inhibitor therapy and outcomes from SARS-..:

Cortellini, A ; Dettorre, G.M ; Dafni, U...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2022-005732. , 2022

Link: https://serval.unil.ch/n..

6

Time-Dependent COVID-19 Mortality in Patients with Cancer: ..:

Pinato D. J ; Patel M ; Scotti L...
info:eu-repo/semantics/altIdentifier/pmid/34817562. , 2022

Link: http://hdl.handle.net/11..

7

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outb..:

Pinato, DJ ; Aguilar-Company, J ; Ferrante, D...
https://discovery.ucl.ac.uk/id/eprint/10152411/1/main%20%2814%29.pdf. , 2022

Link: https://discovery.ucl.ac..

8

Natural immunity to SARS-CoV-2 and breakthrough infections ..:

Cortellini, A ; Aguilar-Company, J ; Salazar, R...
British Journal of Cancer. , 2022

Link: http://hdl.handle.net/10..

9

Co-infections and superinfections complicating COVID-19 in ..:

Gudiol, C ; Durà-Miralles, X ; Aguilar-Company, J...
Journal of Infection, 83 (3), 306-313.. , 2022

Link: https://idus.us.es/handl..

10

Specialist palliative and end-of-life care for patients wit..:

Soosaipillai, G ; Wu, A ; Dettorre, GM...
Therapeutic Advances in Medical Oncology. , 2021

Link: http://hdl.handle.net/10..

11

Co-infections and superinfections complicating COVID-19 in ..:

Gudiol, C ; Durà-Miralles, X ; Aguilar-Company, J...
http://hdl.handle.net/10668/18256. , 2021

Link: http://hdl.handle.net/10..

12

Prevalence and impact of COVID-19 sequelae on treatment and..:

Pinato, DJ ; Tabernero, J ; Bower, M...
https://discovery.ucl.ac.uk/id/eprint/10137799/1/main%20%281%29.pdf. , 2021

Link: https://discovery.ucl.ac..

13

Systemic pro-inflammatory response identifies patients with..:

Dettorre G. M ; Dolly S ; Loizidou A...
info:eu-repo/semantics/altIdentifier/pmid/33753569. , 2021

Link: http://hdl.handle.net/11..

14

Specialist palliative and end-of-life care for patients wit..:

Soosaipillai, G ; Wu, A ; Dettorre, GM...
https://discovery.ucl.ac.uk/id/eprint/10134000/1/17588359211042224%20%281%29.pdf. , 2021

Link: https://discovery.ucl.ac..

15

Systemic pro-inflammatory response identifies patients with..:

Dettorre G. M ; Dolly S ; Loizidou A...
info:eu-repo/semantics/altIdentifier/pmid/33753569. , 2021

Link: http://hdl.handle.net/11..